Right hemicolectomy with ileocolostomy 2.
Right salpingo-oophorectomy .
Left ankle end stage tibiotalar osteoarthritis s/p Left ankle fusion [**2151-10-8**] 8.
Mucocutaneous Junction separated at 7 o'clock to 12 o'clock and at 2 o'clock to 4 o'clock, sutures present, intact where mucocutaneous junction is still intact.
-Midline incisional wound: Approximately 12cm x 3cm x 2cm granulating, clean, intact without exudate.
VAC dressing with black foam continuous pressure at 125mm Hg.
[**2151-10-11**] ABDOMEN (SUPINE & ERECT): Large amount of pneumoperitoneum suggesting viscus perforation.
Large pneumoperitoneum suggesting hollow viscus perforation without definitive source identified, although foci of gas tracking along the right abdomen and pelvis along with irregularity of the cecum make the right colon/cecum suspect.
Uncertain finding.
One week status post ileocolic resection for perforated colon with pneumoperitoneum that it is more than expected for the postoperative period.
[**2151-10-21**] CXR (Portable AP): As compared to the previous radiograph, there is now intubation of the right main bronchus.
The endotracheal tube should be pulled back by 3-4 cm.
The nasogastric tube is in unchanged position.
ANKLE (AP, MORTISE & LA: The patient is status post tibiotalar fusion via two screws.
Microbiology:  [**2151-10-26**] BLOOD CULTURE Blood Culture, Routine-PENDING [**2151-10-26**] BLOOD CULTURE Blood Culture, Routine-PENDING [**2151-10-22**] BLOOD CULTURE, no growth final [**2151-10-22**] CATHETER TIP-IV WOUND CULTURE-FINAL-No growth [**2151-10-22**] URINE URINE CULTURE-FINAL; ANAEROBIC CULTURE-FINAL-No growth [**2151-10-22**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL; ANAEROBIC CULTURE-FINAL-PMLs, GNR.
Screen predicts NO synergy with penicillins or          vancomycin.
Screen predicts NO synergy with penicillins or vancomycin.
Consult ID for treatment options.
Daptomycin = 3 MCG/ML.
[**2151-10-20**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL {ESCHERICHIA COLI}; FUNGAL CULTURE-PRELIMINARY .
[**2151-10-19**] BLOOD CULTURE Blood Culture, Routine-FINAL-No growth [**2151-10-19**] BLOOD CULTURE Blood Culture, Routine-FINAL-No growth [**2151-10-19**] STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL INPATIENT [**2151-10-19**] STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL INPATIENT [**2151-10-19**] URINE URINE CULTURE-FINAL-No growth [**2151-10-18**] MRSA SCREEN MRSA SCREEN-FINAL-Negative [**2151-10-17**] BLOOD CULTURE Blood Culture, Routine-FINAL-No growth [**2151-10-17**] BLOOD CULTURE Blood Culture, Routine-FINAL-No growth [**2151-10-17**] URINE URINE CULTURE-FINAL-No growth [**2151-10-16**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL {ESCHERICHIA COLI, LACTOBACILLUS SPECIES}; ANAEROBIC CULTURE-FINAL .
LACTOBACILLUS SPECIES.
[**2151-10-11**] BLOOD CULTURE Blood Culture, Routine-FINAL-No Growth [**2151-10-11**] URINE URINE CULTURE-FINAL-No growth  Brief Hospital Course: The patient was admitted to the General Surgical Service on [**2151-10-11**] for evaluation and treatment of abdominal pain.
The patient was brought to the Operating Room emergently, where she underwent right hemicolectomy with ileocolostomy primary anastomosis for a finding of peritonitis and ischemic right hemicolon and right colonic perforation.
Propofol and fentanyl infusion given during intubation.
The patient was extubated without problem, and placed on supplemental oxygen by nasal cannula.
She was NPO on IV fluids, an NG tube and foley catheter were in place.
She was continued on IV Flagyl and Cipro for the perforated bowel.
On POD#2, the patient was transferred to the floor NPO, on IV fluids and antibiotics, with a foley catheter, and a Dilaudid PCA for pain control.
The NG Tube, IV antibiotics and foley were discontinued, and the patient was started on sips on POD#3.
These findings nevertheless were consistent with perforation and the patient was consented and brought back to the OR for urgent exploratory laparotomy and probable ileostomy, colostomy and resection.
Early on [**2151-10-18**], the patient underwent exploratory laparotomy, resection of ileocolic anastomosis, [**Doctor Last Name **] ileostomy, transverse end-colostomy, and debridement of fascial edges for identified perforation ileocolic anastomosis, which went well (see Operative Note).
Post-operatively, the patient was transferred to the SICU NPO on IV fluids, back on IV Flagyl and Cipro, with a foley and NG Tube in place, intubated on mechanical ventialtion.
POD#[**8-21**], checked CDiff from both mucous fistula/colostomy & ileostomy, rectal tube placed.
POD#[**10-23**], extubated and well tolerated.
POD#13/6, started on IV Daptomycin for VRE (ENTEROCOCCUS FAECIUM) from blood culture dated [**2151-10-20**].
IV Vancomycin discontinued.
The patient arrived on the floor on a diabetic regular diet, home medications, oral pain medications, and on a comprehensive antibiotics regimen, which consisted of IV Daptomycin and cefepime and oral Flagyl and Ciprofloxacin.
She had a VAC dressing with black foam at 125mmHg applied to her mid-abdominal incisional wound, an ileostomy and colostomy.
She was given repletement for her ostomy output with IV Lactated Ringer's.
She was followed by Orthopedics regarding for the left ankle; she remained non-weight bearing on the left with an ankle splint in place.
The patient tolerated her diabetic regular diet with fair intake, but no nausea.
She was also started on nutritional supplements.
Pain was well controlled on oral pain medications.
Colostomy and ileostomy remained patent.
Oral Cipro and Flagyl were discontinued on [**2151-10-25**].
IV Cefepime was discontinued on [**2151-10-26**].
IV Daptomycin will be continued until [**2151-10-31**].
She experienced episodic left index finger swelling and pain; she was ultimately started on a short course of Indocin with symptomatic improvement.
Her blood sugar was monitored closely and covered when indicated by an insulin sliding scale.
On [**2151-10-28**], she was given a 500mL NS fluid bolus to catch up on fluid losses from the ileostomy.
Imodium PRN was started to maintain an ileosotmy output around the 1L/day volume.
Subsequently, imodium was discontinued on [**2151-10-29**].
The patient is tolerating a regular diet, ileostomy and colostomy are functioning properly, and pain is well controlled.
Medications on Admission: AMITRIPTYLINE - 75 mg hs ATORVASTATIN CALCIUM - 10 MG qday HYDROCHLOROTHIAZIDE - 12.5mg day KETOPROFEN - 75 mg tid LISINOPRIL - 20MG qday METFORMIN - 500 MG [**Hospital1 **] OXYCODONE-ACETAMINOPHEN - 5 mg-325 mg Tablet - 1-2 tabs q4h prn TEMAZEPAM - 15MG hs   Discharge Medications: 1.
Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metformin 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours).
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for agitation, anxiety.
Amitriptyline 75 mg Tablet Sig: One (1) Tablet PO at bedtime.
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Temazepam 15 mg Capsule Sig: One (1) Capsule PO HS (at bedtime).
Daptomycin 600 mg IV Q24H Discontinue after AM dose on [**2151-10-31**].
Insulin Lispro 100 unit/mL Solution Sig: 2-12 units Subcutaneous As directed per Humalog Insulin Sliding Scale.
Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical QID (4 times a day) as needed for itchy skin.
Loperamide 2 mg Capsule Sig: One (1) Capsule PO QID (4 times a day) as needed for for ileostomy output > 40mL/Hr (1L/day).
Medication: HYDROmorphone (Dilaudid) 1 mg IV Q3H:PRN breakthrough pain or before VAC dressing change   Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: Primary: 1.
Ischemic right hemicolon and right colonic perforation.
HTN 3. s/p Left ankle fusion and left tendoachilles lengthening for ankle arthritis [**2151-10-6**] (Prior hospitalization) - ankle splint in place.
Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Monitoring Ileostomy output/Prevention of Dehydration:  *Keep well hydrated.
